Model 6240-37F: Package Insert and Label Information

MODEL 6240-37F-
Aerospace Accessory Service, Inc

Aerospace Accessory Service

Aerospace Accessory Service

P/N:

S/N:

EXP:

Prep. By:

Label
(click image for full-size original)
Established Pharmacological Class
Substance Pharmacological Class
Model 6240-37F First Aid Kit With Drug
MODEL 6240-37F
kit
Product Information
Product Type Item Code (Source) NHRIC:27860-003
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:27860-003-09 1 KIT in 1 PACKAGE None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1
Part 2 1
Part 3 1
Part 4 1
Part 5 1
Part 6 1
Part 7 1
Part 8 1
Part 9 1
Part 1 of 9
ALCOHOL PREP
isopropyl alcohol swab
Product Information
Item Code (Source) NDC:67777-121
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ISOPROPYL ALCOHOL (ISOPROPYL ALCOHOL) ISOPROPYL ALCOHOL 0.7 mL in 1 mL
Inactive Ingredients
Ingredient Name Strength
WATER
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part333A 07/01/2010
Part 2 of 9
TRIPLE ANTIBIOTIC
bacitracin zinc, neomycin sulfate, polymyxin b sulfate ointment
Product Information
Item Code (Source) NDC:55670-600
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
BACITRACIN ZINC (BACITRACIN) BACITRACIN 400 [USP’U] in 1 g
NEOMYCIN SULFATE (NEOMYCIN) NEOMYCIN 3.5 mg in 1 g
POLYMYXIN B SULFATE (POLYMYXIN B) POLYMYXIN B 5000 [USP’U] in 1 g
Inactive Ingredients
Ingredient Name Strength
PETROLATUM
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part333B 07/11/2012 04/15/2022
Part 3 of 9
MOORE MEDICAL NON ASPIRIN
acetaminophen tablet, film coated
Product Information
Item Code (Source) NDC:55670-467
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
HYPROMELLOSES
POLYETHYLENE GLYCOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
SODIUM STARCH GLYCOLATE TYPE A POTATO
STARCH, CORN
STEARIC ACID
TITANIUM DIOXIDE
Product Characteristics
Color white (white) Score no score
Shape ROUND (ROUND) Size 10mm
Flavor Imprint Code AZ;234
Contains
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph not final part343 12/30/2008
Part 4 of 9
NASAL DECONGESTANT
oxymetazoline hcl spray
Product Information
Item Code (Source) NDC:0904-6761
Route of Administration NASAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OXYMETAZOLINE HYDROCHLORIDE (OXYMETAZOLINE) OXYMETAZOLINE HYDROCHLORIDE 0.05 g in 100 mL
Inactive Ingredients
Ingredient Name Strength
BENZYL ALCOHOL
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM
EDETATE DISODIUM
MICROCRYSTALLINE CELLULOSE
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
POLYETHYLENE GLYCOL, UNSPECIFIED
POVIDONE, UNSPECIFIED
WATER
BENZALKONIUM CHLORIDE
Product Characteristics
Color white (to off white, viscous) Score
Shape Size
Flavor Imprint Code
Contains
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part341 10/12/2018
Part 5 of 9
MEDIQUE DIAMODE
loperamide hydrochloride tablet
Product Information
Item Code (Source) NDC:47682-200
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
LOPERAMIDE HYDROCHLORIDE (LOPERAMIDE) LOPERAMIDE HYDROCHLORIDE 2 mg
Inactive Ingredients
Ingredient Name Strength
MAGNESIUM STEARATE
POWDERED CELLULOSE
STARCH, CORN
HYDROGENATED COTTONSEED OIL
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
CROSPOVIDONE
D&C YELLOW NO. 10
FD&C BLUE NO. 1
Product Characteristics
Color green (Green) Score 2 pieces
Shape OVAL (Caplet) Size 10mm
Flavor Imprint Code 123
Contains
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074091 12/30/2008
Part 6 of 9
MOORE MEDICAL ANTACID
calcium carbonate tablet, chewable
Product Information
Item Code (Source) NDC:55670-142
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CALCIUM CARBONATE (CALCIUM CATION) CALCIUM CARBONATE 420 mg
Inactive Ingredients
Ingredient Name Strength
ACACIA
MAGNESIUM STEARATE
MALTODEXTRIN
SUCROSE
Product Characteristics
Color white (white) Score no score
Shape ROUND (ROUND) Size 12mm
Flavor MINT (MINT) Imprint Code FR;8
Contains
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part331 12/30/2008
Part 7 of 9
MOTION SICKNESS
meclizine hcl tablet
Product Information
Item Code (Source) NDC:70677-0026
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE 25 mg
Inactive Ingredients
Ingredient Name Strength
STARCH, CORN
D&C YELLOW NO. 10 ALUMINUM LAKE
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
SILICON DIOXIDE
Product Characteristics
Color yellow Score no score
Shape ROUND Size 9mm
Flavor Imprint Code 44;403
Contains
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part336 06/24/2002
Part 8 of 9
AMMONIA INHALANTS
ammonia inhalants inhalant
Product Information
Item Code (Source) NDC:46414-3333
Route of Administration RESPIRATORY (INHALATION) DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
AMMONIA (AMMONIA) AMMONIA 0.045 g in 0.3 mL
Inactive Ingredients
Ingredient Name Strength
ALCOHOL
FD&C RED NO. 40
WATER
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 02/14/1976
Part 9 of 9
EASY CARE FIRST AID DIPHENHYDRAMINE
diphenhydramine hydrochloride tablet, film coated
Product Information
Item Code (Source) NDC:44224-0017
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE) DIPHENHYDRAMINE HYDROCHLORIDE 25 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
D&C RED NO. 27
HYPROMELLOSES
LACTOSE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
SILICON DIOXIDE
TITANIUM DIOXIDE
Product Characteristics
Color pink (pink) Score no score
Shape OVAL (OVAL) Size 11mm
Flavor Imprint Code 048;D
Contains
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part341 01/01/2012
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
exempt device ABC 01/01/2015
Labeler — Aerospace Accessory Service, Inc (859100547)
Registrant — Aerospace Accessory Service, Inc (859100547)
Establishment
Name Address ID/FEI Operations
Aerospace Accessory Service, Inc 859100547 manufacture, repack

Revised: 05/2021 Aerospace Accessory Service, Inc

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.